Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio, 01877) released an updated list of directors and their committee appointments dated 13 March 2026.

The Board now comprises: • 8 executive directors, led by Chairman and Legal Representative Mr. Xiong Jun, Vice-Chairman Dr. Li Ning, Chief Executive Officer Dr. Zou Jianjun, Co-CEO Mr. Li Cong, and executive directors Mr. Zhang Zhuobing, Dr. Yao Sheng, Dr. Wang Gang and Dr. Li Xin. • 1 non-executive director, Mr. Tang Yi. • 5 independent non-executive directors (INEDs): Mr. Zhang Chun, Dr. Feng Xiaoyuan, Mr. Li Zhongxian, Ms. Lu Kun and Dr. Yang Jin.

Five board committees have been constituted with the following leadership and memberships: 1. Audit Committee – Chair: INED Mr. Zhang Chun; Members: Mr. Tang Yi and INED Mr. Li Zhongxian. 2. Nomination Committee – Chair: INED Dr. Feng Xiaoyuan; Members: Chairman Mr. Xiong Jun and INED Ms. Lu Kun. 3. Remuneration and Appraisal Committee – Chair: INED Mr. Zhang Chun; Members: Chairman Mr. Xiong Jun, INED Dr. Feng Xiaoyuan and INED Dr. Yang Jin. 4. Strategic and ESG Committee – Chair: Chairman Mr. Xiong Jun; Members: CEO Dr. Zou Jianjun and Dr. Wang Gang. 5. Compliance Committee – Chair: INED Ms. Lu Kun; Members: INED Mr. Zhang Chun and INED Mr. Li Zhongxian.

The declared structure aligns Junshi Bio with prevailing corporate governance standards by ensuring that each committee is chaired by an independent director except the Strategic and ESG Committee, which remains under the leadership of Chairman Mr. Xiong Jun.